Displaying 1 to 12 of 12 investments
Company | Country | Date | Notes | ||
---|---|---|---|---|---|
APT Pharmaceuticals Inc A pharmaceutical company focused on repurposing well-characterized drugs for under-served populations. |
United States | 1 Sep 2008 | Series A Initial investment. Round participant. Active |
||
Asthmatx Inc |
United States | Series D |
|||
Barrx Medical Inc Minimally invasive placed single use disposable medical device for the treatment of Barrett’s esophagus. |
United States | N/A Active |
|||
CoMentis Inc |
United States | N/A |
|||
EnteroMedics Inc Develops therapeutic devices for the treatment of obesity. Its VSM technology uses electrical signals, delivered by an implantable electrode array, to |
United States | N/A |
|||
Great Lakes Pharmaceuticals Inc Developer of an anti-infective lock solution to address in-dwelling venous catheter mediated infection. |
United States | 1 Aug 2010 | Series B |
||
Intarcia Therapeutics Inc A biopharmaceutical company applying a targeted approach to the acquisition, development and commercialization of novel therapeutic products for the t |
United States | N/A |
|||
Kereos Inc Kereos, Inc. develops targeted molecular imaging agents and therapeutics designed to detect and treat cancer and cardiovascular disease. |
United States | N/A |
|||
KFx Medical Corp |
United States | N/A |
|||
Mirabilis Medica Inc Developer of non-invasive ultrasound technology for the treatment of uterine fibroids |
United States | N/A |
|||
Revascular Therapeutics Inc |
United States | N/A |
|||
Xlumena Inc Xlumena is a medical device company. |
United States | 1 Apr 2011 | Series B |